Acousia Therapeutics
Tübingen, Germany· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Acousia Therapeutics GmbH is a privately held German biotech company founded in 2012 and based in Tübingen. It is dedicated to developing novel small molecule therapeutics to enhance and preserve natural hearing in patients with sensorineural hearing loss (SNHL). The company's lead candidate, ACOU085 (bimokalner), is in Phase 2 trials, targeting a significant unmet medical need.
Small Molecules